Association between Anti-Human Immunodeficiency Virus Type 1 (HIV-I) Antibody-Dependent Cellular Cytotoxicity Antibody Titers at Birth and Vertical Transmission of HIV-I
Marjorie Jenkins(United States Food and Drug Administration), Steve Kohl(University of California, San Francisco), Hunter A. Hammill(Baylor College of Medicine), Daniel V. Landers(University of California, San Francisco), William T. Shearer(Baylor College of Medicine), R. R. iscarello(University of California, San Francisco), D. W. Wara(University of California, San Francisco), Edwin D. Charlebois, Mark W. Kline(Tulane University), Debora Williams‐Herman(University of California, San Francisco)
Cited by 33
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
|AIDS|2000|1k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Viral Load and Disease Progression in Infants Infected with Human Immunodeficiency Virus Type 1
|New England Journal of Medicine|1997|551